Chester County News and Community Website
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, announced positive preliminary topline results from a 12-week, Phase …
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has granted the first conditional approval under its expanded authority to KBroVet-CA1 (potassium bromide chewable tablets) to control seizures in dogs …
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration released the agency’s first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a …
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has approved the first generic of glucagon for injection USP, 1 mg/vial packaged in an emergency kit, for the treatment of …
Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that it has resubmitted the New Drug …
Read More
EXTON, PA — Almirall, S.A. (BME: ALM), a global biopharmaceutical company focused on skin health, announced that Klisyri® (tirbanibulin) has been approved by the U.S. Food and Drug Administration (FDA) for the topical …
Read More
DEVON, PA — Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, has provided an update on its meeting with …
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has issued an emergency use authorization (EUA) for the first over-the-counter (OTC) fully at-home diagnostic test for COVID-19. The Ellume COVID-19 …
Read More EXTON, PA — Almirall, S.A. (BME: ALM), a global biopharmaceutical company focused on skin health, announced that Klisyri® (tirbanibulin) has been approved by the U.S. Food and Drug Administration (FDA) …
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has authorized the first diagnostic test for at home collection of patient samples to detect both COVID-19 and influenza A and …
Read More